Abstract
Aim: Several wordings of the definition of severe hypoglycaemia (SH) exist. This study aims to evaluate how different SH definition wordings affect SH history assessment. Methods: In this cross-sectional study, surveys were emailed to registrants of the T1D Exchange, a U.S. national type 1 diabetes patient registry. Participants' demographic information was collected. Six-month SH history was evaluated with questionnaires including SH definition wordings from either (1) professional societies, (2) a diabetes community website, or (3) a hypoglycaemia research questionnaire. Analyses included the McNemar test, pairwise Wilcoxon signed-rank test, logistic regression analysis, Kappa statistics, and Spearman correlation. Results: A total of 1580 valid responses were obtained from participants (52% female; mean ± SD age: 46 ± 15 years; 95% White; mean ± SD diabetes duration: 25 ± 16 years). Questionnaires with four different SH definition wordings yielded significant variations in the prevalence of SH (i.e., having developed at least one episode of SH) and the number of SH episodes: the ADA/ENDO 2013 definition wording yielded the highest results on both metrics, whereas HypoA-Q and ADA 2023 yielded the lowest. Among participants reporting at least one SH episode, the number of episodes identified with the different SH definition wordings was poorly correlated (Rs: 0.09–0.37; p < 0.001). Race, education level, and household income were associated with higher odds of discrepancies in SH history (p < 0.05). Conclusion: This U.S. national survey with individuals living with type 1 diabetes demonstrated significant discrepancies in SH history when assessed with different SH definition wordings. Race and socioeconomic status were associated with these discrepancies.
Original language | English |
---|---|
Article number | e15513 |
Journal | Diabetic Medicine |
Volume | 42 |
Issue number | 4 |
DOIs | |
State | Published - Apr 2025 |
Bibliographical note
Publisher Copyright:© 2025 The Author(s). Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK.
Funding
This work was supported by the Michigan Centre for Clinical and Translational Research (P30DK092926). Y.K.L. was supported by NIH K23DK129724 and the University of Michigan Caswell Diabetes Institute. Support to SJF from NIH DK118082, DK135111, and the University of Kentucky Barnstable Brown Diabetes and Obesity Centre is acknowledged. REDCap was supported by NCATS UM1TR004404.
Funders | Funder number |
---|---|
University of Michigan Caswell Diabetes Institute | |
Michigan Centre for Clinical and Translational Research | P30DK092926 |
National Institutes of Health (NIH) | K23DK129724 |
National Institutes of Health (NIH) | |
National Center for Advancing Translational Sciences (NCATS) | UM1TR004404 |
National Center for Advancing Translational Sciences (NCATS) |
Keywords
- clinical trial
- epidemiological studies
- hypoglycaemia
- type 1 diabetes mellitus
ASJC Scopus subject areas
- Internal Medicine
- Endocrinology, Diabetes and Metabolism
- Endocrinology